Position in NVS
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$16,587,733
+$3,421,424 QoQ
Shares Held
108,594
+13.7% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
1.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026EXENCIAL WEALTH ADVISORS, LLC holds $76,718,350 across 13 Drug Manufacturers - General names. NVS ranks #1 (21.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVS |
Novartis AG
This page
|
108,594 | $16,587,733 | |
| 2 | LLY |
ELI LILLY & Co
|
17,141 | $15,765,777 | |
| 3 | JNJ |
Johnson & Johnson
|
41,920 | $10,246,924 | |
| 4 | ABBV |
AbbVie Inc.
|
41,150 | $8,949,713 | |
| 5 | AMGN |
Amgen Inc
|
17,401 | $6,122,541 | |
| 6 | AZN |
Astrazeneca PLC
|
20,162 | $3,976,349 | |
| 7 | SNY |
Sanofi
|
81,382 | $3,920,984 | |
| 8 | GSK |
GSK plc
|
55,198 | $3,046,377 |
All Filings in NVS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $16,587,733 | 108,594 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $13,166,309 | 95,498 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $12,301,293 | 95,924 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $11,909,320 | 98,416 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $13,156,758 | 118,019 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $12,275,364 | 126,147 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $14,624,102 | 127,144 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $14,040,796 | 131,888 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $13,648,312 | 141,097 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $14,544,324 | 144,046 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $15,276,759 | 149,978 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $15,727,025 | 155,852 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $15,505,220 | 168,535 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $15,925,986 | 175,551 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $13,547,870 | 178,238 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $13,382,197 | 158,313 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $14,077,118 | 160,423 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $15,788,247 | 180,499 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $23,370,025 | 285,767 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $18,809,217 | 206,151 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $18,950,573 | 221,696 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $18,872,213 | 199,854 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $20,206,982 | 232,371 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $19,351,574 | 221,566 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $17,933,617 | 217,509 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||